---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-26-003132"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2026-06-10T10:01:19+00:00"
generated_at: "2026-06-10T10:07:04.206897+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# InMed regains Nasdaq minimum bid price compliance; deficiency closed

## Summary
- Received Nasdaq notice on June 3, 2026 that bid price was at or above $1.00 for 10 consecutive business days (May 19–June 2).
- Previously notified of deficiency on March 27, 2026 for bid price below $1.00 for 30 consecutive days.
- Nasdaq has closed the matter; Company remains listed on the Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001062993-26-003132
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2026-06-10T10:01:19+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000106299326003132/0001062993-26-003132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000106299326003132/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-26-003132
- JSON: https://secwatch.observer/filing/0001062993-26-003132.json
- Plain text: https://secwatch.observer/filing/0001062993-26-003132.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.